17 Dec Low Cost Pain Treatment Your Doctor Probably Doesn’t Know About
A 2018 Dartmouth-Hitchcock Medical Center study concluded that “based on current reports of numerous benefits and an excellent safety profile, clinical use of Low Dose Naltrexone or ‘LDN’ may be seen as a reasonable option in patients with fibromyalgia or irritable bowel disease.”
This 18 page
paper also serves as an excellent resource for exploring this low cost treatment option. This review discusses the properties of naltrexone, mechanism of action of low dosing and summaries of clinical trials of LDN for Multiple Sclerosis, Complex Regional Pain Syndrome, Fibromyalgia, GI disorders, dermatological conditions and cancer.
Fibromyalgia Results
32.5% symptom reduction for LDN versus 2.3% on placebo
57% of patients responded
Patients’ satisfaction with life and mood was significantly better while taking LDN
LDN had same side effects as placebo
Irritable Bowel Disease Results
Majority responded with a 70-point decrease in Crohn’s disease activity index (89%) and achieved remission (67%)
Drug was safe and tolerable and LDN provided clinical benefits
Clinical improvement in majority (74.5%) of patients who previously had intractable disease, while some (25.5%) achieved remission
LDN use was associated with significant reduction in consumption of anti-inflammatory medications
LDN is a low cost option with few side effects which studies are showing to be effective in treating pain, irritable bowel disease, mental health and autoimmune conditions. Your health care provider doesn’t know about it because it’s almost 60 years old so no drug companies are promoting it.
You can learn more about how LDN could treat your chronic pain conditions by filling out this Consultation Form. We will then be able to make a recommendation to your doctor based on the information you give us.
Check out our events page to find out when our next LDN webinar is! We look forward to seeing you there!